Research Article

Blood Oxidative Stress Marker Aberrations in Patients with Huntington’s Disease: A Meta-Analysis Study

Table 1

Characteristics of included studies measuring peripheral blood markers.

No.Study and yearCountry or regionSample sizeGender (M/F)Mean age (years)CAG-RNOS markers measuredSample sourceDiagnosis criteria

1Stoy 2005UKHD 113/8NANAMDA and 4-hydroxynonenal; tryptophan metabolitesSerumNA
HC 154/11NA
2Hersch 2006USAHD 32NANANA8-OHdGSerumUHDRS
HC 32
3Chen 2007TaiwanHD 169/748.445.0MDA; 8-OHdG; SOD; and GPxPlasma, serum, and erythrocyteUHDRS
HC 3619/1753.0
4Klepac 2007CroatiaHD 1914/54645.0MDA; GSH; and SODPlasmaUHDRS
HC 4731/1641
5Duran 2010SpainHD 2410/1448.445.1LPOPlasmaUHDRS
HC 6030/3048.0
6Leoni 2011ItalyHD 12757/7052.144.6CholesterolPlasmaUHDRS
HC 13467/6848.2
7Salvatore 2011ItalyHD 1710/748.844.8Cholesterol; LDL; and HDLBloodUHDRS
HC 1710/749.2
8Tunez 2011SpainHD 199/1043.546.58-OHdG; LPO; GSH; SOD; GPx; cholesterol; HDL; LDL; and triglyceridesPlasma, erythrocyteUHDRS
HC 198/1142.2
9Ciancarelli 2014ItalyHD 1813/551.1NA8-OHdG; SOD; cholesterol; HDL; and triglyceridesSerum, plasmaUHDRS
HC 104/650.0
10Wang 2014USAHD 85/357.642.5Cholesterols; HDL; LDL; and triacylglycerolsPlasmaNA
HC 85/357.0
11Peña-Sánchez 2015CubaHD 148/650.045.0Cholesterol; triglycerides; MDA; GSH; SOD; and GPxSerumUHDRS
HC 2912/1748.0
12Nielsen 2016DenmarkHD 7036/3351.543.3CholesterolBloodUHDRS
HC 4018/2241.4

HD: Huntington’s disease; HC: healthy controls; M/F: male/female; CAG-RN: cytosine-adenine-guanine repeat number; OS: oxidative stress; MDA: malondialdehyde; LPO: lipid peroxidation products; 8-OHdG: 8-hydroxyguanosine; GSH: glutathione; GPx: glutathione peroxidase; SOD: superoxide dismutase; LDL: low-density lipoprotein; HDL: high-density lipoprotein; UHDRS: Unified Huntington’s Disease Rating Scales; NA: not available.